Co-Delivery of Silymarin and Metformin Dual-Loaded in Mesoporous Silica Nanoparticles Synergistically Sensitizes Breast Cancer Cell Line to Mitoxantrone Chemotherapy-Reference-Cited by-同舟云学术

Co-Delivery of Silymarin and Metformin Dual-Loaded in Mesoporous Silica Nanoparticles Synergistically Sensitizes Breast Cancer Cell Line to Mitoxantrone Chemotherapy

Published:2023-10 Issue:4 Volume:22 Page:872-880
ISSN:1536-1241
Container-title:IEEE Transactions on NanoBioscience
language:
Short-container-title:IEEE Trans.on Nanobioscience

Author:

Rezaei Harandi Zahra¹,Heidari Razieh²,Reiisi Somayeh¹^ORCID

Affiliation:

1. Department of Genetics, Faculty of Basic Sciences, Shahrekord University, Shahrekord, Iran

2. Department of Medical Biotechnology, School of Advanced Technologies, Shahrekord University of Medical Sciences, Shahrekord, Iran

Publisher

Institute of Electrical and Electronics Engineers (IEEE)

Subject

Electrical and Electronic Engineering,Computer Science Applications,Pharmaceutical Science,Biomedical Engineering,Medicine (miscellaneous),Bioengineering,Biotechnology

Link

http://xplorestaging.ieee.org/ielx7/7728/10269102/10043763.pdf?arnumber=10043763

Reference35 articles.

1. Silymarin nanoemulsion against human hepatocellular carcinoma: development and optimization

2. Increase in apoptosis by combination of metformin with silibinin in human colorectal cancer cells

3. Metformin and cancer: An existing drug for cancer prevention and therapy;zi;Oncol Lett,2018

4. Effects of Silymarin-Loaded Nanoparticles on HT-29 Human Colon Cancer Cells

5. Progress in Mesoporous Silica Nanoparticles as Drug Delivery Agents for Cancer Treatment

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances in mesoporous silica nanoparticles formulations and drug delivery for wound healing;International Journal of Pharmaceutics;2024-11

2. Hippophae Rhamnoides‐derived Phytomedicine Nano‐System Modulates Bax/Fas Pathways to Reduce Proliferation in Triple‐Negative Breast Cancer;Advanced Healthcare Materials;2024-08-12

3. Nanomedicine-Based Drug-Targeting in Breast Cancer: Pharmacokinetics, Clinical Progress, and Challenges;ACS Omega;2023-12-13